MTOR and cancer: As discussed above, major molecular mechanisms are involved in the regulation of PKM2 by LncRNA in cancer development and treatment, which are classified into conventional molecular signaling pathways including PTEN-PI3K-Akt-mTOR and P53, protein alternative splicing, and miRNA-associated ceRNA mechanisms.